European Alliance of Associations for Rheumatology Sjögren's Syndrome Disease Activity Index (ESSDAI)
Showing 1 - 25 of >10,000
Sjögren and Gynecologic Considerations
Completed
- Primary Sjögren Syndrome
- +3 more
- Visual analogue scale (VAS) for dyspareunia
- +3 more
-
Ankara, TurkeyAnkara City Hospital
Jan 3, 2023
Sjogren's Syndrome (SS) Trial in Utrecht (Ravaglimab, Ravagalimab, Placebo)
Withdrawn
- Sjogren's Syndrome (SS)
- Ravaglimab
- +2 more
-
Utrecht, NetherlandsUniversitair Medisch Centrum Utrecht /ID# 214029
Jan 20, 2022
Sjogren's Syndrome, Fatigue, Pain Syndrome Trial in Yildirim (FACT-F questionnaire, Beck Depression Inventory, Beck Anxiety
Completed
- Sjogren's Syndrome
- +5 more
- FACT-F questionnaire
- +6 more
-
Yıldırım, Bursa, TurkeyKoray Ayar
Nov 29, 2021
Sjogren's Syndrome Trial (Anifrolumab)
Recruiting
- Sjogren's Syndrome
- Anifrolumab
- Placebo
-
Groningen, NetherlandsUniversity Medical Centre Groningen
Dec 16, 2022
Primary Sjögren's Syndrome Trial in Worldwide (S95011 concentrate for solution for infusion, Placebo concentrate for solution
Active, not recruiting
- Primary Sjögren's Syndrome
- S95011 concentrate for solution for infusion
- Placebo concentrate for solution for infusion
-
Beverly Hills, California
- +27 more
Jan 13, 2023
Sjögren's Syndrome Trial in Worldwide (Deucravacitinib, Placebo)
Not yet recruiting
- Sjögren's Syndrome
- Deucravacitinib
- Placebo
-
Santa Monica, California
- +25 more
Jul 19, 2023
Superb Microvascular Imaging Ultrasonography of Lacrimal Gland
Recruiting
- Inflammation
- +2 more
- Superb Microvascular Imaging (SMI) (Toshiba)
-
Niğde, TurkeyNigde Omer Halisdemir University
Jan 10, 2023
Sjögren Syndrome, Sicca Syndrome Trial in São Paulo (N-acetylcysteine syrup, Placebo syrup)
Active, not recruiting
- Sjögren Syndrome
- Sicca Syndrome
- N-acetylcysteine syrup
- Placebo syrup
-
São Paulo, Sao Paulo, Brazil
- +1 more
Jun 13, 2022
Sjogren Syndrome, Mixed Connective Tissue Disease Trial in Worldwide (MHV370, Placebo)
Recruiting
- Sjogren Syndrome
- Mixed Connective Tissue Disease
- MHV370
- Placebo
-
Guangzhou, Guangdong, China
- +18 more
Jul 29, 2022
Sjogren Syndrome Trial (VAY736, Placebo)
Not yet recruiting
- Sjogren Syndrome
- VAY736
- Placebo
- (no location specified)
Jul 14, 2022
Sjögren's Syndrome Trial in Beijing (low-dose interleukin-2, rapamycin)
Recruiting
- Sjögren's Syndrome
- low-dose interleukin-2
- rapamycin
-
Beijing, Beijing, ChinaPeking university people's hospital
Dec 2, 2022
Sjogren Syndrome Trial (VAY736, Placebo)
Not yet recruiting
- Sjogren Syndrome
- VAY736
- Placebo
- (no location specified)
Jul 14, 2022
Primary Sjögren Syndrome Patients
Active, not recruiting
- Sjogren's Syndrome
- Parallel Assignment
-
São Paulo, Sao Paulo, Brazil
- +1 more
Nov 7, 2022
Rheumatoid Arthritis Trial (Treatment target DAS28CRP-LDA, Treatment target SDAI-remission)
Not yet recruiting
- Rheumatoid Arthritis
- Treatment target DAS28CRP-LDA
- Treatment target SDAI-remission
- (no location specified)
Sep 13, 2023
Sjogren's Syndrome Trial in Beijing (Baricitinib, Hydroxychloroquine)
Recruiting
- Sjogren's Syndrome
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 17, 2022
Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
Completed
- Small Fiber Neuropathy
- Primary Sjögren Syndrome
- cutaneous silent period (CSP) measurement
-
Istanbul, Pendik, TurkeyMarmara University Pendik Education and Research Hospital
May 16, 2022
Primary Sjögren's Syndrome Trial in Hangzhou (Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets)
Recruiting
- Primary Sjögren's Syndrome
- Iguratimod Tablets
- Hydroxychloroquine Sulfate Tablets
-
Hangzhou, Zhejiang, ChinaSecond affiliated hospital of zhejiang university,school of medi
Mar 23, 2022
Sjögren Syndrome Trial in Worldwide (LOU064, Placebo)
Primary Sjögren's Syndrome Trial in Yantai (Placebo, RC18 240 mg, RC18 160 mg)
Completed
- Primary Sjögren's Syndrome
- Placebo
- +2 more
-
Yantai, Shandong, ChinaRemegen,Ltd.
Jan 7, 2022
Intestinal Microbiota in Gougerot-Sjögren Syndrome According to
Recruiting
- Sjogren's Syndrome
- Biomarker detection
-
Nîmes, FranceCHU de Nimes
May 24, 2022
Primary Sjögren Syndrome Trial in Rochester (Ustekinumab)
Completed
- Primary Sjögren Syndrome
-
Rochester, New YorkUniversity of Rochester
Jul 6, 2022
Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis Trial in São Paulo (Recombinant Herpes Zoster Vaccine (RZV),
Recruiting
- Rheumatoid Arthritis
- +9 more
- Recombinant Herpes Zoster Vaccine (RZV)
- +5 more
-
São Paulo, Sao Paulo, BrazilRheumatology Division of Hospital das Clínicas da Faculdade de M
May 24, 2023